Biodesix, Inc. ( BDSX) - Key Metrics
BDSX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $3.57 | -$0.49 | $0.10 | $0.08 |
| 2025Q3 | $2.90 | -$1.16 | -$1.18 | -$1.19 |
| 2025Q2 | $2.73 | -$1.56 | -$0.90 | -$0.90 |
| 2025Q1 | $2.45 | -$1.52 | -$1.17 | -$1.19 |
BDSX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.44 |
| 2025Q3 | ? | -1.62 |
| 2025Q2 | ? | -0.90 |
| 2025Q1 | ? | -2.06 |
BDSX
Price: $21.14
52 week price:
Earnings Per Share: -3.96 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 306900
Market Capitalization: 179.0 million